Related by context. All words. (Click for frequent words.) 70 anticancer therapies 67 conjugate vaccines 67 mAbs 66 NNRTIs 66 antiviral therapy 66 siRNA therapeutics 66 antiviral compounds 65 recombinant vaccines 65 therapies 65 predictive biomarkers 65 nucleoside analogues 64 antisense drugs 64 MEK inhibitors 64 nanoviricides 64 therapeutic regimens 64 NEUGENE 64 therapeutic monoclonal antibodies 64 molecularly targeted therapies 64 immunotoxins 63 imatinib Gleevec 63 GeoVax vaccine 63 biologic therapies 63 Lodamin 63 protease inhibitors 63 proteasome inhibitors 63 NovaBay Aganocide compounds 63 siRNA compounds 63 radezolid 63 therapeutic monoclonal antibody 63 CBLC# 63 oncolytic viruses 63 Altastaph 62 polymerase inhibitors 62 lentiviral vectors 62 humanized monoclonal antibodies 62 Symadex 62 prophylactic vaccines 62 CXCR4 receptor 62 diagnostic biomarkers 62 thiazolides 62 antisense oligonucleotides 62 iPSC 62 PARP inhibitors 62 humanized antibody 62 BCR ABL inhibitors 62 cytotoxics 62 immunotherapeutics 62 monovalent vaccine 62 immunomodulators 62 immunotherapies 62 monoclonal antibody therapies 62 anti angiogenic drugs 62 peptide antigens 62 Thiovir 62 anticancer agents 62 chemotherapeutics 61 Interferon alpha 61 MMP inhibitors 61 preclinically 61 molecularly targeted 61 proteasome inhibitor 61 LNP formulations 61 lentiviral vector 61 antiviral therapeutics 61 interferons 61 imatinib resistance 61 HuLuc# 61 antigen sparing 61 poliovirus vaccine 61 vaccinology 61 alpha interferon 61 virotherapy 61 OncoVEX 61 OHR/AVR# 61 rifamycins 61 JAK inhibitors 61 antiplatelet therapies 61 LHRH antagonists 61 Bcr Abl mutations 61 chemopreventive agents 61 DermaVir 61 lipid nanoparticle 61 molecular assays 61 covalent drugs 61 CCR5 inhibitors 61 trivalent vaccine 61 oncolytic virus 61 live attenuated vaccines 61 pegylated interferons 61 immunosuppressive therapies 61 antisense compounds 61 EGFR inhibitors 60 antiretroviral therapies 60 transfection reagents 60 HIV protease inhibitors 60 nucleoside analogue 60 cancer immunotherapies 60 XmAb# 60 combination antiretroviral therapy 60 HCV 60 biologic therapeutics 60 viral hemorrhagic fevers 60 gamma secretase inhibitors 60 targeting PCSK9 60 cytotoxic agents 60 HCV infections 60 Cytolin R 60 XmAb 60 JAK3 60 virosomes 60 clade B 60 nucleoside analogs 60 Smac mimetics 60 oral antiviral 60 bivalent vaccine 60 nanoviricide 60 inactivated influenza vaccines 60 Cytolin ® 60 DAS# [001] 60 multitargeted 60 reverse vaccinology 60 MAbs 60 small molecule activators 60 inhibit replication 60 PEGylated 60 Gleevec resistant 60 HCV protease inhibitors 60 JNJ Q2 60 Th2 cytokines 60 molecular biomarkers 60 fusion inhibitor 60 immunosuppressive regimens 60 AMN# [001] 60 humanized antibodies 60 siRNA therapeutic 60 echinocandins 60 viral vectors 60 anti CD# antibodies 60 chemotherapeutic agents 60 inhibit viral replication 60 nucleotide analogs 60 Multimeric 60 histone deacetylase inhibitors 60 druggable targets 60 delta isoform 60 TLR9 agonist 60 personalized immunotherapy 60 neuraminidase inhibitors 60 aptamers 60 SERMs 60 nanomedicines 60 prophylactic vaccine 60 BRAF inhibitors 59 A3 adenosine receptor 59 SGLT2 inhibitors 59 nucleotide analog 59 Epothilones 59 immunotherapy 59 epigenetic therapies 59 recombinant subunit vaccine 59 cMET 59 Fc fusion protein 59 monoclonal antibody MAb 59 small molecule inhibitors 59 humanized mouse 59 antisense drug 59 immunogens 59 ROTARIX 59 novel peptide 59 HBV vaccine 59 Respiratory Syncytial Virus RSV 59 hemorrhagic fever viruses 59 multivalent vaccine 59 dasatinib Sprycel 59 Phylomer ® 59 VitiGam 59 anti angiogenic agents 59 anticancer drugs 59 pharmacologic intervention 59 TNFa 59 NPM1 59 parainfluenza virus 59 Curaxins 59 immune modulators 59 nonvaccine 59 retroviral vectors 59 antibody therapeutics 59 ganetespib 59 tumor antigens 59 direct thrombin inhibitors 59 lipid lowering therapies 59 fluoroquinolone antibiotic 59 investigational monoclonal antibody 59 pandemic influenza strains 59 transgenic rats 59 anti tubercular 59 TLR agonists 59 recombinant antibodies 59 ketolide antibiotic 59 Alnylam RNAi 59 RNAi therapeutic targeting 59 proprietary PEGylation 59 P. falciparum parasites 59 immunotherapeutic approaches 59 biodegradable nanoparticles 59 HCV infection 59 anticancer therapeutics 59 antifungal drugs 59 VEGF inhibitors 59 TRIM5a 59 meningococcal vaccines 59 Aliskiren 59 adenovirus vectors 59 Raltegravir 59 recombinant vaccine 59 ErbB3 HER3 59 adjuvanted vaccines 59 antisense inhibitors 59 NS4A 59 immunotoxin 59 delafloxacin 59 D 1mT 59 Blinatumomab 59 heterologous 59 CMV vaccine 59 viral strains 59 deacetylase inhibitors 59 nucleosides 59 plasmid DNA vaccine 59 influenza VLP vaccines 59 MyVax R 59 chemotherapeutic 59 Novosom 59 oncolytic 59 rxRNA compounds 59 DNA plasmids 59 chemotherapeutic drugs 59 Locked Nucleic Acid LNA 59 UsiRNAs 59 anti CD3 59 Ramoplanin 59 immunomodulatory 59 influenza vaccines 59 nucleotide analogues 59 CYT# potent vascular disrupting 59 Anticalins 59 therapies ACTs 59 Squalamine 59 IAP inhibitors 59 Dicer Substrate Technology 58 DiLA2 58 ALK inhibitors 58 dSLIM 58 quinolone 58 neovascular diseases 58 monoclonal 58 DsiRNA 58 synthetic lethality 58 epithelial tumors 58 synthetic peptides 58 Sphingomab 58 Onconase 58 aminoglycosides 58 Nanobody ® 58 immunosuppressive agents 58 ddRNAi 58 monoclonal antibodies 58 Insegia 58 meropenem 58 aptamer therapeutics 58 daptomycin 58 respiratory viruses 58 hematopoietic cells 58 signal transduction inhibitors 58 macrolide antibiotics 58 tigecycline 58 adamantanes 58 AEG# 58 therapeutic modalities 58 oral prodrug 58 cancer immunotherapy 58 imatinib Gleevec ® 58 anti idiotype 58 chlamydial 58 monoclonals 58 monoclonal antibody therapeutics 58 artemisinins 58 Kinase inhibitors 58 anticoagulant reversing agent 58 antibody mediated 58 HTS assay 58 HSP# inhibitors 58 monoclonal antibody mAb 58 AdVac ® 58 IgG1 antibody 58 azoles 58 TPI ASM8 58 targeting CD# 58 antithrombotic agents 58 protease inhibitor PI 58 Epstein Barr virus EBV 58 indinavir 58 Universal Influenza Vaccine 58 pox viruses 58 AMPK activators 58 HSP# inhibitor 58 DepoVax TM 58 Human cl 58 integrase inhibitors 58 monoclonal antibodies MAbs 58 cellular immunotherapy 58 TTR gene 58 anti infective treatments 58 CCR5 antagonist 58 otelixizumab 58 Corus CAD 58 myeloproliferative disorders 58 selective inhibitors 58 neutralizing antibody 58 rxRNA TM compounds 58 DNA methylation biomarkers 58 peptide therapeutics 58 Therapeutic antibodies 58 kinase inhibitors 58 interferon gamma 58 Tarvacin Anti Viral 58 mda 7 58 lapatinib Tykerb 58 Ebola vaccine 58 broadly neutralizing antibodies 58 adefovir dipivoxil 58 Neugene 58 DermaVir Patch 58 antiangiogenesis 58 human microdosing 58 fusion proteins 58 OMP #M# 58 ENMD # 58 nonviral 58 TNF alpha inhibitors 58 diagnostic assays 58 transcutaneous immunization TCI 58 CCR5 antagonists 58 immunomodulator 58 DepoVax ™ 58 VZV 58 FLU v 58 resistant microorganisms 58 interferon 58 viral subtypes 58 TroVax ® 58 antifungal therapy 58 SARMs 58 chemical entities NCEs 58 biotherapies 58 subunit vaccine 58 undruggable targets 58 CD8 T cells 58 CD# antibodies 58 poxvirus 58 CDDO Im 58 intranasal delivery 58 immunosuppressed patients 58 serogroup B 58 botulinum neurotoxin 58 ALN PCS 58 DGAT1 inhibitors 58 Gefitinib 58 theranostics 58 Anticalins R 58 VDAs 58 SCIB1 58 efavirenz Sustiva 58 valent pneumococcal conjugate vaccine 58 renin inhibitors 58 PI3K inhibitors 57 xenograft models 57 P. vivax 57 influenza subtypes 57 GPCR targets 57 Panzem R NCD 57 OncoVEX GM CSF 57 JAK2 inhibitors 57 Vaccine Candidate 57 TRAIL receptor antibodies 57 staphylococcal infections 57 vidofludimus 57 SIgN 57 Telbivudine 57 therapeutic modality 57 adenoviral vectors 57 protein antigens 57 Vidofludimus 57 macrolides 57 Novavax VLP vaccine 57 GRNVAC1 57 BioVant 57 NITD# 57 hepatitis C virus 57 mucosal immunity 57 INT# [002] 57 methylation markers 57 nucleoside 57 CCR5 receptor antagonist 57 Candida species 57 ESBA# 57 hormone gastrin 57 Profectus BioSciences 57 JAK2 inhibitor 57 Vaxfectin 57 ISF# 57 miltefosine 57 transfection reagent 57 glycopeptides 57 act synergistically 57 maturation inhibitors 57 Tarvacin 57 vaccine adjuvants 57 nucleoside analog 57 Fludara ® 57 Deforolimus 57 integrase inhibitor 57 multiplex assay 57 selective inhibition 57 immunomodulation 57 PROCHYMAL 57 recombinants 57 adeno associated viruses 57 immunotherapeutic vaccine 57 pDCs 57 T#I [002] 57 kidney urologic 57 NEUGENE antisense 57 thalidomide Thalomid 57 NS#/#A protease 57 pneumococci 57 neuraminidase inhibitor 57 suppress viral replication 57 murine antibodies 57 Omacetaxine 57 velafermin 57 subunit vaccines 57 vaccines 57 drug ISA# 57 viral polymerase 57 cilengitide 57 antisense RNA 57 Pertuzumab 57 Piperacillin 57 beta interferons 57 vaginal microbicides 57 ASC J9 57 topical microbicide 57 Copegus ribavirin 57 CCR5 inhibitor 57 therapeutics 57 therapeutically useful 57 Cancidas 57 IRX 2 57 Alferon N 57 biodefense countermeasure 57 ChronVac C R 57 synthetic retinoid 57 Dapagliflozin 57 dAbs 57 flavopiridol 57 pegfilgrastim 57 immunological responses 57 therapeutic mAbs 57 Intravenous CP 57 busulfan 57 torezolid 57 oral anticoagulants 57 antimalarial drug 57 beta lactam antibiotic 57 rxRNA ™ compounds 57 immunoregulation 57 cyclophilin inhibitors 57 prognostic markers 57 Dendritic Cell 57 Aviptadil 57 neutralizing antibodies 57 chimeric protein 57 hypervirulent strains 57 NKT cells 57 hormonal therapies 57 selective kinase inhibitor 57 PlGF 57 tyrosine kinase inhibitors 57 HCV polymerase inhibitors 57 Nanobodies 57 Velcade bortezomib 57 YONDELIS 57 rituximab Rituxan 57 Hepatitis C Virus HCV 57 ImQuest 57 Cylene 57 TH# cells 57 adenovector 57 biomarker identification 57 NNRTI resistant 57 NEUGENE R 57 forodesine 57 Nanobodies ® 57 HDAC inhibitors 57 superantigens 57 DOS# 57 CA4P 57 Pralatrexate 57 angiogenesis inhibitor 57 vaccine TIV 57 Personalized Immunotherapy 57 Alinia 57 tubulin inhibitor 57 ganciclovir 57 Alferon LDO 57 antisense therapies 57 eTag assays 57 Reverset 57 VIR# 57 EGFR TKIs 57 saquinavir 57 apricitabine 57 antiviral drugs 57 interferon IFN 57 Bcr Abl inhibitors 57 GelSite R polymer 57 Marburg viruses 57 Transfection Reagent 57 costimulation 57 oncology therapeutics 57 tipranavir 57 systemic fungal infections 57 inhibit metastasis 57 immune modulating 57 SNALP 57 investigational integrase inhibitor 57 adenovirus vector 57 TRV# [001] 57 mAb 57 mtDNA mutations 57 Candida glabrata 57 K ras mutations 57 tyrosine kinase inhibitor 57 Sustiva efavirenz 57 antifungal agents 57 CTAP# Capsules 57 BACcel 57 resolvins 57 caspofungin 57 respiratory viral infections 57 affinity antibodies 57 tumor antigen 57 Factor VIIa 57 viral pathogenesis 57 TLR Therapeutics 57 hedgehog pathway 57 oral JAK1 57 protease inhibitors PIs 57 ALN TTR# 57 inhibitor RG# 57 T SPOT.TB 56 conjugate vaccine 56 Interferon alfa 56 ALN TTR 56 xTAG RVP 56 inhibiting tumor 56 Xencor XmAb 56 diagnostic biomarker 56 VLP vaccine candidate 56 Zolinza 56 Bilive TM 56 PRTX 56 quinolones 56 Protease inhibitors 56 antimitotic 56 potent antiretroviral therapy 56 chemotherapies 56 Chimigen 56 dengue viruses 56 bacterial strains 56 Elvitegravir 56 neuroprotective therapies 56 RNAi therapeutic 56 Viprovex TM 56 cidofovir 56 systemic RNAi 56 interferon lambda 56 transcriptase inhibitor 56 TNF alpha antagonist 56 fusion inhibitors 56 herpes infections 56 integrase 56 pDNA vaccines 56 IMA# 56 anticancer therapy 56 ProMune 56 prostone 56 subcutaneous immunoglobulin 56 Factor IX 56 exon skipping 56 Cethromycin 56 P. vivax malaria 56 immunodeficiency disorders 56 vorinostat 56 MenACWY 56 Lpathomab 56 Vitaxin 56 HspE7 56 CD8 responses 56 biologic pathways 56 CCX# 56 pharmacological chaperone 56 Dyax phage display 56 nifurtimox 56 Epidermal Growth Factor Receptor 56 Imatinib 56 U1 Adaptors 56 non nucleoside 56 RNA therapeutics 56 cediranib 56 PIK3CA 56 Dasatinib 56 thrombopoietin 56 Fuzeon enfuvirtide 56 EGFR antibodies 56 apoptotic pathway 56 pathogenic mechanisms 56 HIV protease 56 AAV vector 56 Hsp# inhibitors 56 bioinformatic approaches 56 M. pneumoniae 56 NPC 1C 56 intracellular pathogens 56 recombinant hepatitis B 56 Panzem 56 TCAD therapy 56 ImmunoVEX HSV2 56 HQK 56 c MET 56 LNPs 56 JAK1 56 antituberculosis drugs 56 Cancer Vaccines 56 Sodroski 56 S. suis 56 pneumococcal serotypes 56 Monoclonal antibodies 56 epothilone 56 herpes zoster vaccine 56 FGFR 56 abzymes 56 artemesinin 56 Pseudomonas aeruginosa infections 56 candidemia 56 attenuated strain 56 novel RNAi therapeutics 56 pharmacogenetic testing 56 angiogenesis inhibition 56 adoptive immunotherapy 56 immunological diseases 56 epigenetic mechanisms 56 hematological malignancy 56 vascular disrupting agents 56 vemurafenib 56 bryostatin 56 MVA BN R 56 ALI ARDS 56 investigational therapies 56 hydroxychloroquine 56 Candida infections 56 reemerging infectious diseases 56 mycophenolate mofetil 56 chemotherapeutic regimens 56 EGFR pathway 56 siRNA delivery 56 TKIs 56 Achaogen 56 Helicobacter pylori H. pylori 56 antiplatelet agents 56 LY# [003] 56 enzyme reverse transcriptase 56 Campath alemtuzumab 56 CCR9 antagonist 56 peptidomimetic 56 bendamustine HCl 56 oseltamivir Tamiflu 56 intradermal injection 56 S. maltophilia 56 simplex virus 56 curative therapies 56 OnDose TM 56 protein kinase inhibitors 56 infliximab Remicade 56 Herceptin trastuzumab 56 faropenem 56 atrasentan 56 HIV integrase inhibitors 56 p# inhibitors 56 hepatitis C viral infection 56 Maraviroc 56 PCV7 vaccine 56 antibody 56 synthetic analogues 56 inactivated vaccine 56 viral pathogens 56 next generation URAT1 56 novel immunotherapies 56 antibodies 56 HAART regimens 56 Vaxfectin TM 56 Ceflatonin 56 tranilast 56 vitro assay 56 MediVas 56 erlotinib Tarceva ® 56 Talabostat 56 HDACi 56 shRNA libraries 56 Gleevec imatinib mesylate 56 BRAF inhibitor 56 zidovudine AZT 56 fluoroquinolone resistance 56 SynCon 56 single stranded oligonucleotides 56 secretory diarrhea 56 pandemic influenza virus 56 herpesviruses 56 tyrosine kinase inhibitor TKI 56 VAX# 56 effector function 56 ZFP Therapeutic 56 genetic biomarkers 56 rifabutin 56 Viral Immunotherapy platform 56 TransVax ™ 56 antisense 56 kinase inhibition 56 multidrug resistance 56 protein therapeutics 56 potent inhibitors 56 JVRS 56 nanomolar 56 humanised monoclonal antibody 56 immunomodulatory therapy 56 Epstein Barr Virus EBV 56 enzyme inhibitors 56 RNA antagonists 56 antibody therapies 56 virulence genes 56 CEQ# 56 Immunotherapy 56 influenza antivirals 56 therapeutic antibodies 56 radionuclide therapy 56 Dalbavancin 56 PRT# 56 VLPs 56 LC#m# 56 Chlamydia trachomatis 56 RAV# 56 noscapine 56 targeted antifolate 56 OncoVex 56 Combination therapy 56 EGFR tyrosine kinase inhibitors 56 Valortim R 56 quinacrine 56 KL4 surfactant 56 gemifloxacin 56 Isis antisense 56 enzastaurin 56 trivalent influenza vaccine 56 cephalosporin antibiotics 56 Cerashield 56 antagomirs 56 investigational humanized monoclonal antibody 56 vaccine 56 parthenolide 56 multidrug resistant strains 56 Fibroblast Growth Factor Receptor 56 short interfering RNA 56 standard chemotherapy regimens 56 hypereosinophilic syndrome 56 GelVac TM 56 nucleotide analogue 56 pertuzumab 56 PNT# 56 antiviral 56 FLT3 56 Gag polymorphisms 56 intracellular bacteria 56 AZT zidovudine Retrovir 56 E. histolytica 56 glycosylated 56 P#X# 56 anti mitotic 55 BRAF mutation 55 Chimigen TM 55 pharmacologic approaches 55 synthetic siRNAs 55 Intelence 55 metaglidasen 55 AAV vectors 55 Human Papillomavirus 55 Immunotherapeutic 55 chronic HCV infection 55 pneumococcus 55 naturally occurring antibodies 55 RNA antagonist 55 latent infection 55 pneumococcal infection 55 TransVax TM 55 pharmacological approaches 55 peptide synthesis 55 KRAS mutation 55 Trichomonas vaginalis 55 resistant pathogens 55 maraviroc 55 cathepsin K 55 pan HDAC inhibitor 55 Therapeutic Vaccine 55 NRTI resistance 55 Sym# 55 Neisseria gonorrhoeae 55 M.tb 55 Pervasis 55 biodefense pathogens 55 olaparib 55 DepoVax 55 VIRxSYS 55 antiangiogenesis therapies 55 seasonal influenza vaccines 55 trastuzumab Herceptin ® 55 somatostatin analogue 55 co stimulatory molecules 55 cellular reprogramming 55 Monoclonal antibody 55 HCV protease 55 S/GSK# 55 ChronVac C ® 55 NNRTI 55 theranostic 55 erlotinib Tarceva 55 endostatin 55 gamma secretase inhibitor 55 Ad5 vector 55 Excelimmune 55 RhuDex ® 55 Virosome Biologicals 55 CHIKV 55 Treg cell 55 THR beta agonist 55 pandemic influenza viruses 55 calcineurin inhibitors 55 siRNA sequences 55 SynCon TM 55 Combivir Kivexa 55 Tofacitinib 55 invasive fungal infections 55 Japanese Encephalitis vaccine 55 NS5b 55 GAP #B# 55 HERmark 55 Plasmodium falciparum 55 Haptoglobin 55 chronic viral infections 55 anti TNF 55 HepDirect prodrug 55 amphotericin B 55 chemotherapeutic drug 55 stavudine d4T 55 small molecule thrombopoietin 55 carbohydrate compounds 55 HCV polymerase inhibitor 55 detecting colorectal cancer 55 PROSTVAC VF 55 HCV replicon 55 visilizumab 55 microbicides 55 immunomodulating 55 virus AAV 55 EGF receptor 55 CD# antibody [001] 55 tenofovir DF 55 TMEM#B 55 PDGF receptor 55 superinfection 55 Trp p8 55 myelofibrosis polycythemia vera 55 protein misfolding diseases 55 Etubics 55 GPx 55 Gleevec imatinib 55 Amantadine 55 etravirine 55 biomarkers 55 commercialize deforolimus 55 recombinant therapies 55 MabThera rituximab 55 IGFBP2 55 Helicobacter 55 Dengue viruses 55 antitumoral 55 NNR Therapeutics 55 PCV# 55 macrolide resistance 55 intranasal vaccine 55 carbapenem 55 anionic backbone 55 aminoglycoside 55 cervical precancerous lesions 55 Carfilzomib 55 intracellular signaling pathways 55 pneumococcus bacteria 55 CD#L 55 Staphylococcus aureus infections 55 Antiviral drugs 55 Hedgehog inhibitor 55 beta lactams 55 pre exposure prophylaxis 55 immune modulation 55 intradermal vaccine 55 SynCon ™ 55 Virulizin ® 55 IMPDH 55 novel antibody therapeutics 55 regenerative medicine therapies 55 N. gonorrhoeae 55 lenalidomide dexamethasone 55 pegylation 55 lentiviral 55 TLR9 agonists 55 ProNAi 55 live attenuated influenza 55 lupus nephritis 55 AFFITOME technology 55 Eraxis 55 oral proteasome inhibitor 55 gastrin 55 agonistic human 55 nonnucleoside reverse transcriptase inhibitors 55 Azedra 55 S. pneumoniae 55 depsipeptide 55 glycan microarray 55 ACTCellerate 55 immunosuppressant therapies 55 Merck Isentress 55 Curaxin 55 pharmacogenetics 55 nitazoxanide 55 intranasal vaccines 55 tenofovir Viread 55 selective modulator 55 TBC M4 55 pharmacogenetic 55 HuCAL antibodies 55 biochemical profiling 55 antibody fragment 55 plasmid DNA pDNA 55 insulin analogs 55 CMV retinitis 55 BCG vaccine 55 gefitinib Iressa 55 virosome 55 dasatinib 55 epigenetic therapeutics 55 Hemopurifier TM 55 smallpox vaccines 55 Saquinavir 55 Scancell 55 Monoclonal Antibodies 55 Smac mimetic 55 influenza strains 55 treatment regimens 55 Viramidine 55 Metallophile ™ Technology 55 poxviruses 55 sarcosine 55 TB bacterium 55 neutralizing antibody responses 55 Radilex 55 FluINsure 55 non adjuvanted vaccines 55 LymphoStat B 55 HCV replication 55 MAPCs 55 amantadine Symmetrel 55 Bacillus Calmette Guerin BCG 55 antithrombotics 55 lipid nanoparticles 55 viral antigens 55 Monoclonal 55 FTIs 55 Spiegelmers R 55 prognostic biomarkers 55 CXCL5